W.E. Fibbe

587 total citations
25 papers, 474 citations indexed

About

W.E. Fibbe is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, W.E. Fibbe has authored 25 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 6 papers in Immunology and 4 papers in Genetics. Recurrent topics in W.E. Fibbe's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). W.E. Fibbe is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). W.E. Fibbe collaborates with scholars based in Netherlands, Germany and United States. W.E. Fibbe's co-authors include Venkata Lokesh Battula, Peter de Zwart, Thomas Skutella, Suzanne Treml, Friederike Gieseke, Petra M. Bareiss, H.‐J. Bühring, Ingo Müller, Helene Roelofs and Lothar Kanz and has published in prestigious journals such as The Lancet, Blood and European Journal of Cancer.

In The Last Decade

W.E. Fibbe

24 papers receiving 461 citations

Peers

W.E. Fibbe
Olga Gurevitch Israel
Terry A. Hewett United States
U. F. Gorskaya Russia
Chantal Rapatel France
Hossein Mossafa France
Nadia Sessarego Italy
Nathalie Boiret France
Jodie Harrington United Kingdom
Angelo Tocci Italy
MR Koller United States
Olga Gurevitch Israel
W.E. Fibbe
Citations per year, relative to W.E. Fibbe W.E. Fibbe (= 1×) peers Olga Gurevitch

Countries citing papers authored by W.E. Fibbe

Since Specialization
Citations

This map shows the geographic impact of W.E. Fibbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.E. Fibbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.E. Fibbe more than expected).

Fields of papers citing papers by W.E. Fibbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.E. Fibbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.E. Fibbe. The network helps show where W.E. Fibbe may publish in the future.

Co-authorship network of co-authors of W.E. Fibbe

This figure shows the co-authorship network connecting the top 25 collaborators of W.E. Fibbe. A scholar is included among the top collaborators of W.E. Fibbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.E. Fibbe. W.E. Fibbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ball, L.M., Maria Ester Bernardo, Maarten J. D. van Tol, et al.. (2011). Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children. Bone Marrow Transplantation. 46. 1 indexed citations
2.
Battula, Venkata Lokesh, Suzanne Treml, Petra M. Bareiss, et al.. (2008). Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 94(2). 173–184. 271 indexed citations
3.
Velders, Gerjo A., Hans Pruijt, Ronald van Os, et al.. (1999). Antibodies to the beta 2-integrins LFA-1 and Mac-1 synergistically enhance stem cell mobilization induced by G-CSF. Experimental Hematology. 27. 113–113. 1 indexed citations
4.
Pruijt, Hans, Carl G. Figdor, Yvette van Kooyk, R. Willemze, & W.E. Fibbe. (1997). No expression of LFA-1 on murine hematopoietic progenitor cells with colony-forming or radioprotective capacity. Blood. 90. 3 indexed citations
5.
Fibbe, W.E., Hans Pruijt, L. Laterveer, et al.. (1997). Mechanisms of stem cell mobilization in mice. Experimental Hematology. 25. 6–6. 1 indexed citations
6.
Fibbe, W.E., et al.. (1997). Mechanisms of stem cell mobilization. European Journal of Cancer. 33. S5–S5. 2 indexed citations
7.
Willemze, Roel, Marian Stevens‐Kroef, Robby E. Kibbelaar, et al.. (1997). 71 Clonality of hematopoiesis in myelodysplasia. Leukemia Research. 21(1). S19–S19.
8.
9.
Vermeer, B.J., et al.. (1994). Skin biopsies in bone marrow transplantation. The Lancet. 344(8915). 75–76. 4 indexed citations
10.
Velders, Gerjo A., W.E. Fibbe, P. M. Kluin, & R. Bieger. (1994). Autologous bone marrow transplantation for intra-abdominal extramedullary plasmacytoma. Annals of Hematology. 69(5). 261–264. 2 indexed citations
11.
Verduyn, Willem, J. J. van Rood, Frans H.J. Claas, et al.. (1994). The use of HLA-DPB1 matching in selecting matched unrelated bone marrow donors. Human Immunology. 39(2). 127–127. 1 indexed citations
12.
Wessels, J.W., W.E. Fibbe, J. E. Landegent, et al.. (1993). t(5;12)(q31;p12) A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics. 65(1). 7–11. 50 indexed citations
13.
Dreef, EJ, H van Kamp, W.E. Fibbe, et al.. (1993). Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood. 82(3). 904–913. 3 indexed citations
14.
15.
Kamp, H van, EJ Dreef, Hanneke C. Kluin‐Nelemans, et al.. (1992). Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood. 79(7). 1823–1828. 8 indexed citations
16.
Kibbelaar, R.E., H van Kamp, EJ Dreef, et al.. (1991). Detection of trisomy 8 in hematological disorders by in situ hybridization. Cytogenetic and Genome Research. 56(3-4). 132–136. 53 indexed citations
17.
Fibbe, W.E., et al.. (1988). Proliferation of hematopoietic progenitor cells in long-term bone-marrow cultures (ltbmc) and the release of colony-stimulating factors (csfs) by human stromal cells is stimulated by interleukin-1-beta (il-1). 7(3). 290–290. 1 indexed citations
18.
Fibbe, W.E., Jo Van Damme, Alfons Billiau, et al.. (1988). Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony- stimulating factor. Blood. 71(2). 430–435. 13 indexed citations
19.
Voogt, P.J., W.E. Fibbe, W. F. J. Veenhof, et al.. (1987). Cell-mediated lysis of human hematopoietic progenitor cells.. PubMed. 1(5). 427–31. 12 indexed citations
20.
Gratama, J.W., W.E. Fibbe, Theo Stijnen, et al.. (1986). Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease.. PubMed. 1(2). 141–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Gurevitch Breakdown of academic impact, for papers by Terry A. Hewett Breakdown of academic impact, for papers by U. F. Gorskaya Breakdown of academic impact, for papers by Chantal Rapatel Breakdown of academic impact, for papers by Hossein Mossafa Breakdown of academic impact, for papers by Nadia Sessarego Breakdown of academic impact, for papers by Nathalie Boiret Breakdown of academic impact, for papers by Jodie Harrington Breakdown of academic impact, for papers by Angelo Tocci Breakdown of academic impact, for papers by MR Koller
Rankless by CCL
2026